[HTML][HTML] Mechanism of anchoring of OmpA protein to the cell wall peptidoglycan of the gram-negative bacterial outer membrane
The outer membrane protein A (OmpA) plays important roles in anchoring of the outer
membrane to the bacterial cell wall. The C-terminal periplasmic domain of OmpA (OmpA-like …
membrane to the bacterial cell wall. The C-terminal periplasmic domain of OmpA (OmpA-like …
Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins
…, KB Ku, BT Kim, EC Park, HG Kim, SI Kim - Biosensors and …, 2021 - Elsevier
Coronavirus disease 2019 (COVID-19) is a newly emerged human infectious disease caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a global pandemic, …
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a global pandemic, …
A metazoan ortholog of SpoT hydrolyzes ppGpp and functions in starvation responses
In nutrient-starved bacteria, RelA and SpoT proteins have key roles in reducing cell growth
and overcoming stresses. Here we identify functional SpoT orthologs in metazoa (named …
and overcoming stresses. Here we identify functional SpoT orthologs in metazoa (named …
Acinetobacter baumannii outer membrane protein a modulates the biogenesis of outer membrane vesicles
…, JH Lee, CW Choi, HY Kim, JS Park, SI Kim… - The Journal of …, 2012 - Springer
Acinetobacter baumannii secretes outer membrane vesicles (OMVs) during both in vitro and
in vivo growth, but the biogenesis mechanism by which A. baumannii produces OMVs …
in vivo growth, but the biogenesis mechanism by which A. baumannii produces OMVs …
[HTML][HTML] Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen
HY Kim, BY Ahn, Y Cho - The EMBO journal, 2001 - embopress.org
Inactivation of the retinoblastoma (Rb) tumor suppressor by Simian virus 40 (SV40) large T
antigen is one of the central features of tumorigenesis induced by SV40. Both the N‐terminal …
antigen is one of the central features of tumorigenesis induced by SV40. Both the N‐terminal …
The crystal structure of flap endonuclease-1 from Methanococcus jannaschii
KY Hwang, K Baek, HY Kim, Y Cho - nature structural biology, 1998 - nature.com
Flap endonuclease-1 (FEN-1), a structure specific nuclease, is an essential enzyme for
eukaryotic DNA replication and repair. The crystal structure of FEN-1 from Methanococcus …
eukaryotic DNA replication and repair. The crystal structure of FEN-1 from Methanococcus …
Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis
SH Cho, A Nam, HY Kim, DB Chay, KH Park… - American journal of …, 2008 - Elsevier
OBJECTIVE: The aim of this study was to evaluate the long-term clinical effects of a
levonorgestrel-releasing intrauterine device (LNG-IUD) on adenomyosis. STUDY DESIGN: A LNG-…
levonorgestrel-releasing intrauterine device (LNG-IUD) on adenomyosis. STUDY DESIGN: A LNG-…
Wireless portable bioelectronic nose device for multiplex monitoring toward food freshness/spoilage
…, J Kim, K Kim, S Phyo, J Lee, HY Kim, M Kim… - Biosensors and …, 2022 - Elsevier
Monitoring food freshness/spoilage is important to ensure food quality and safety. Current
methods of food quality monitoring are mostly time-consuming and labor intensive processes …
methods of food quality monitoring are mostly time-consuming and labor intensive processes …
[HTML][HTML] Neutrophil-to-lymphocyte ratio as an adjunct to CA-125 for the diagnosis of endometriosis
SH Cho, H Cho, A Nam, HY Kim, YS Choi, KH Park… - Fertility and sterility, 2008 - Elsevier
OBJECTIVE: To investigate the clinical value of differential white blood cell counts and
neutrophil-to-lymphocyte ratio (NLR), by themselves or as adjunct to CA-125, in the diagnosis of …
neutrophil-to-lymphocyte ratio (NLR), by themselves or as adjunct to CA-125, in the diagnosis of …
[HTML][HTML] Targeted degradation of⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology
J Lee, KW Sung, EJ Bae, D Yoon, D Kim… - Molecular …, 2023 - Springer
Background There are currently no disease-modifying therapeutics for Parkinson’s disease (PD).
Although extensive efforts were undertaken to develop therapeutic approaches to …
Although extensive efforts were undertaken to develop therapeutic approaches to …